MARQUISHA HINES: Open Payments
NPI 1720851033 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 21 payments from 9 companies in 2025. Trend: 2023 $53 · 2024 $247 · 2025 $558
Food & beverage: $556Education: $2
| Company | Payments | Amount |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 3 | $167 |
| Otsuka America Pharmaceutical, Inc. | 5 | $126 |
| Fresenius USA Marketing, Inc. | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: LUPKYNIS, JYNARQUE, VELPHORO, Kerendia, TARPEYO, FARXIGA, Empaveli, JARDIANCE.
Industry payments across GA — which companies pay providers there.
